MOCH KENNETH I 4
4 · Zynerba Pharmaceuticals, Inc. · Filed Jun 16, 2022
Insider Transaction Report
Form 4
MOCH KENNETH I
Director
Transactions
- Award
Common Stock
2022-06-14+23,109→ 28,109 total - Award
Stock Option (right to buy)
2022-06-14+34,663→ 34,663 totalExercise: $1.01Exp: 2032-06-14→ Common Stock (34,663 underlying) - Sale
Common Stock
2022-06-14$1.01/sh−40$40→ 28,069 total
Footnotes (3)
- [F1]The restricted stock award vests in full upon the earlier of (i) June 14, 2023 or (ii) the day before the Company's 2023 annual meeting of stockholders.
- [F2]This transaction represents shares required to be sold by the Reporting Person to satisfy certain equity plan administrator fees in connection with the vesting of shares of restricted stock. This sale was mandated by the equity plan administrator and does not represent a discretionary trade by the Reporting Person.
- [F3]The option vests in full upon the earlier of (i) June 14, 2023 or (ii) the day before the Company's 2023 annual meeting of stockholders.